Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering Dorzolamide HCl.

Client Email

Product

Dorzolamide HCl
HEALTH CANADA PATENTS

Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Dorzolamide HCl

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

37 API Suppliers, 14 USDMF, 13 CEP/COS, 4 JDMF, 8 EU WC, 12 KDMF, 14 NDC API, 27 Listed Suppliers, $ API Reference Price

37 API Suppliers
14 USDMF
13 CEP/COS
4 JDMF
8 EU WC
12 KDMF
14 NDC API
27 Listed Suppliers
$ API Reference Price

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Imports

INTERMEDIATES

9 API Suppliers

9 API Suppliers

FINISHED DOSAGE FORMULATIONS

174 FDF Dossiers, 35 FDA Orange Book, 96 Europe, 17 Canada, 4 Australia, 7 South Africa, 15 Listed Dossiers

174 FDF Dossiers
35 FDA Orange Book
96 Europe
17 Canada
4 Australia
7 South Africa
15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION/DROPS;OPHTHALMIC - EQ 2% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION/DROPS;OPHTHALMIC - EQ 2% BASE;EQ 0.5% BASE

SOLUTION/DROPS;OPHTHALMIC - EQ 2% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION/DROPS;OPHTHALMIC - EQ 2% BASE;EQ 0.5% BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 12 SPI Pharma, 3 DKSH, 1 Pfanstiehl, 4 Actylis, 1 BASF, 1 Finar, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 2 Kerry, 2 Microlex e.U, 1 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

1 Rochem International Inc
12 SPI Pharma
3 DKSH
1 Pfanstiehl
4 Actylis
1 BASF
1 Finar
2 Gangwal Chemicals
1 Ingredion Pharma Solutions
2 Kerry
2 Microlex e.U
1 Pluviaendo
3 Roquette
1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 10 Chewable & Orodispersible Aids, 9 Taste Masking, 9 Direct Compression, 5 Parenteral, 4 Thickeners and Stabilizers, 3 Granulation, 3 Topical, 3 Rheology Modifiers, 3 Co-Processed Excipients, 3 Disintegrants & Superdisintegrants, 2 Solubilizers, 2 Controlled & Modified Release, 1 API Stability Enhancers

17 Fillers, Diluents & Binders
10 Chewable & Orodispersible Aids
9 Taste Masking
9 Direct Compression
5 Parenteral
4 Thickeners and Stabilizers
3 Granulation
3 Topical
3 Rheology Modifiers
3 Co-Processed Excipients
3 Disintegrants & Superdisintegrants
2 Solubilizers
2 Controlled & Modified Release
1 API Stability Enhancers

DIGITAL CONTENT

16 NEWS #PharmaBuzz

16 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 76 Finished Drug Prices

4 US Medicaid Prescriptions
76 Finished Drug Prices

MARKET PLACE

14 APIs, 1 FDF Dossiers

14 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 4 USP, 4 JP, 6 Others

3 EDQM
4 USP
4 JP
6 Others

$ API Ref.Price (USD/KG) : 3,061 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2Merck Canada Inc.

filter Patent Reset all filters

2 All

01 21329211

filter Product Reset all filters

2 All

01 2Dorzolamide Hydrochloride

filter Dosage Reset all filters

2 All

01 2Ophthalmic Solution

filter Exp Date Reset all filters

2 All

01 22011-05-03

Product Main Page

01

Merck Canada Inc.

Dorzolamide Hydrochloride

AAPS 2024

Not Confirmed

Merck Canada Inc.

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-05-03

Date Granted : 1994-05-03

Dorzolamide Hydrochloride

Brand Name : TRUSOPT PRESERVATIVE-FREE

Patent Number : 1329211

Filing Date : 1988-06-23

Strength per Unit : 2% dorzolamide hydrochloride

Dosage Form : Ophthalmic Solution

Human Or VET : Human

Route of Administration : Ophthalmic

Patent Expiration Date : 2011-05-03

Date Granted : 1994-05-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Merck Canada Inc.

Dorzolamide Hydrochloride

AAPS 2024

Not Confirmed

Merck Canada Inc.

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-05-03

Date Granted : 1994-05-03

Dorzolamide Hydrochloride

Brand Name : TRUSOPT

Patent Number : 1329211

Filing Date : 1988-06-23

Strength per Unit : 20 mg/ml (2%)

Dosage Form : Ophthalmic Solution

Human Or VET : Human

Route of Administration : Ophthalmic

Patent Expiration Date : 2011-05-03

Date Granted : 1994-05-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?